To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NDUFA11andFUT5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
416 supporting clones for gene NDUFA11andFUT5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP432135   .a 1 to 407 1 to 407   tiling clone,   407/416
(97 %)
6 diff
(98.6 %id)
NM_001193375.1   .a 5 to 2637 1 to 2633 exact RefSeq,   2633/2633
(100 %)
0 diff
(100 %id)
AW959323   .a 22 to 600 1 to 581   tiling clone,   581/583
(99 %)
11 diff
(98.2 %id)
FN114810 breast carcinoma .a 220 to 303 87 to 3     Submitted on the opposite strand 85/88
(96 %)
0 diff
(100 %id)
BM746702 Ascites, stomach .a 228 to 589 29 to 391       363/391
(92 %)
8 diff
(98.0 %id)
FN056546 breast carcinoma .a 231 to 297 67 to 1     Submitted on the opposite strand 67/73
(91 %)
2 diff
(97.3 %id)
BQ671667 epidermoid carcinoma, cell line, salivary gland .a 231 to 580 1 to 350       350/350
(100 %)
0 diff
(100 %id)
AK127692   .a 232 to 2637 1 to 2406 S160G T221A tiling clone, available from FLJ,   2406/2406
(100 %)
12 diff
(99.6 %id)
FN106868 breast carcinoma .a 232 to 306 1 to 74       74/74
(100 %)
6 diff
(91.9 %id)
DA695358   .a 233 to 808 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BE835589 prostate_normal .a 235 to 575 20 to 360       341/360
(94 %)
6 diff
(98.4 %id)
W03477 melanocyte .a 244 to 619 1 to 371       371/475
(78 %)
8 diff
(98.4 %id)
N56722.
matches multiple genes
placenta .a 246 to 554 9 to 316     also hits gene SNTB1 308/316
(97 %)
8 diff
(97.5 %id)
FN128850 breast carcinoma .a 248 to 320 74 to 1     Submitted on the opposite strand 74/76
(97 %)
1 diff
(98.7 %id)
BI768307 pooled lung and spleen .a 248 to 625 1 to 379       379/512
(74 %)
2 diff
(99.7 %id)
TI_57178388   .a 248 to 625 73 to 451       379/584
(64 %)
8 diff
(98.7 %id)
BQ925096 epidermoid carcinoma, cell line, lung .a 259 to 973 1 to 715   tiling clone,   715/723
(98 %)
4 diff
(99.5 %id)
BQ955016 epidermoid carcinoma, cell line, lung .a 259 to 973 1 to 715   tiling clone,   715/720
(99 %)
3 diff
(99.6 %id)
DW459593 Liver .a 262 to 397 11 to 146       136/146
(93 %)
5 diff
(96.6 %id)
AA339090 brain .a 267 to 569 1 to 302       302/302
(100 %)
2 diff
(99.4 %id)
AA321675   .a 270 to 607 1 to 337       337/337
(100 %)
3 diff
(99.2 %id)
H37956 eye, retina .a 274 to 634 1 to 361       361/361
(100 %)
12 diff
(96.7 %id)
AA096465   .a 279 to 561 1 to 282       282/282
(100 %)
8 diff
(97.2 %id)
H52452 liver and spleen .a 282 to 601 1 to 319       319/367
(86 %)
7 diff
(98.1 %id)
H93869 liver and spleen .a 282 to 596 1 to 316       316/316
(100 %)
10 diff
(96.9 %id)
EC536901 Prostate .a 283 to 389 1 to 106       106/106
(100 %)
5 diff
(95.3 %id)
D81749 brain .a 289 to 620 1 to 325       325/338
(96 %)
11 diff
(96.8 %id)
R62581 placenta .a 289 to 596 1 to 310       310/310
(100 %)
12 diff
(96.2 %id)
AA385131 thyroid gland .a 290 to 609 1 to 323       323/323
(100 %)
12 diff
(96.3 %id)
EL947312 eyeball .a 292 to 580 1 to 289       289/289
(100 %)
5 diff
(98.3 %id)
F19162 pectoral muscle (after mastectomy) .a 297 to 614 1 to 318       318/318
(100 %)
0 diff
(100 %id)
R07769 liver and spleen .a 298 to 614 1 to 325       325/391
(83 %)
25 diff
(93.7 %id)
CN370509 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 304 to 575 1 to 272       272/272
(100 %)
2 diff
(99.3 %id)
BF807039 colon_ins .a 325 to 553 37 to 265       229/279
(82 %)
7 diff
(97.5 %id)
H06430 placenta .a 332 to 601 1 to 268       268/269
(99 %)
9 diff
(96.7 %id)
AW800130 uterus .a 333 to 581 251 to 1       251/270
(92 %)
8 diff
(97.1 %id)
AJ574237 pectoral muscle (after mastectomy) .a 346 to 580 1 to 236       236/236
(100 %)
4 diff
(98.4 %id)
AJ346618 pectoral muscle (after mastectomy) .a 379 to 581 1 to 203       203/203
(100 %)
1 diff
(99.6 %id)
AW997424 breast_normal .a 1909 to 2603 687 to 1     Submitted on the opposite strand 687/714
(96 %)
19 diff
(97.4 %id)
AW997426 breast_normal .a 1933 to 2609 671 to 1     Submitted on the opposite strand 671/671
(100 %)
9 diff
(98.7 %id)
AW997419 breast_normal .a 1972 to 2585 612 to 3     Submitted on the opposite strand 610/612
(99 %)
0 diff
(100 %id)
AW997430 breast_normal .a 1981 to 2577 604 to 12     Submitted on the opposite strand 593/690
(85 %)
0 diff
(100 %id)
DB323261   .a 2248 to 2637 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
H57398 liver and spleen .b 1 to 282 1 to 282   tiling clone, to resequence,   282/282
(100 %)
2 diff
(99.3 %id)
H57350 liver and spleen .b 381 to 777 395 to 1   tiling clone, to resequence,   395/404
(97 %)
10 diff
(97.6 %id)
TI_159706080   .c 1 to 618 765 to 149 R7V Q8S Y9T W10G D11I ... tiling clone, AAA   617/929
(66 %)
17 diff
(98.2 %id)
TI_159705710   .c 10 to 618 752 to 144 R7V Q8S Y9T W10G D11I ... tiling clone, AAA   609/864
(70 %)
25 diff
(97.2 %id)
H28747 breast .c 11 to 273 1 to 263   tiling clone, fully sequenced,   263/263
(100 %)
12 diff
(95.5 %id)
H28774 breast .c 243 to 603 371 to 13   tiling clone, fully sequenced,   359/371
(96 %)
4 diff
(99.0 %id)
R50670 breast .c 260 to 614 360 to 1   tiling clone,   360/362
(99 %)
13 diff
(96.5 %id)
NM_175614.3   .d 1 to 798 1 to 798 exact RefSeq, AAA   798/798
(100 %)
0 diff
(100 %id)
AL548562 placenta, Placenta Cot 25-normalized .d 12 to 798 1 to 788 G33A L34* tiling clone,   788/788
(100 %)
5 diff
(99.4 %id)
BE731269 choriocarcinoma, placenta .d 60 to 789 1 to 734 A122G S123L L124P V125G K126Q ...     734/984
(74 %)
21 diff
(97.9 %id)
AV702505 adrenal gland .d 196 to 796 1 to 600 A113V A114V V141C tiling clone, AAA   600/600
(100 %)
5 diff
(99.2 %id)
BF667450 brain, primitive neuroectoderm .d 213 to 798 1 to 582 E82R K83S D85T D86T L88E ... AAA   582/596
(97 %)
9 diff
(98.5 %id)
BF678851 Prostate .d 220 to 787 1 to 568 G67R A68G V69R F70V G71R ...     568/569
(99 %)
22 diff
(96.2 %id)
BX474573   .d 223 to 742 1 to 520 exact     520/520
(100 %)
0 diff
(100 %id)
CB155266 brain .d 224 to 721 1 to 498       498/498
(100 %)
0 diff
(100 %id)
CD246517 embryonic stem cells, WA01, passage 38 .d 224 to 794 21 to 591 exact AAA   571/591
(96 %)
6 diff
(99.0 %id)
DB462806 hippocampus .d 224 to 683 1 to 460       460/460
(100 %)
7 diff
(98.5 %id)
DB474579 hippocampus .d 224 to 711 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
BQ878104 epidermoid carcinoma, cell line, salivary gland .d 227 to 798 1 to 572 exact AAA   572/572
(100 %)
0 diff
(100 %id)
BQ675702 epidermoid carcinoma, cell line, salivary gland .d 227 to 798 1 to 572 exact     572/575
(99 %)
1 diff
(99.9 %id)
BQ671956 epidermoid carcinoma, cell line, salivary gland .d 227 to 798 1 to 572 exact AAA   572/572
(100 %)
0 diff
(100 %id)
BG705935 brain, hypothalamus .d 228 to 794 1 to 567 K138N P139T AAA   567/567
(100 %)
8 diff
(98.6 %id)
BU597259 mixed (pool of 40 RNAs) .d 228 to 796 1 to 569 exact     569/573
(99 %)
4 diff
(99.4 %id)
BI090715 cervix .d 232 to 803 1 to 574 exact     574/601
(95 %)
7 diff
(98.9 %id)
DB499148 hypothalamus .d 233 to 721 1 to 489       489/489
(100 %)
2 diff
(99.6 %id)
AL701695 human skeletal muscle .d 237 to 796 1 to 560 F136X     560/563
(99 %)
5 diff
(99.2 %id)
BQ639640 eye, retina .d 237 to 662 8 to 433       426/433
(98 %)
7 diff
(98.4 %id)
R71313 placenta .d 237 to 526 1 to 290   fully sequenced,   290/290
(100 %)
6 diff
(98.0 %id)
DR002018 fetal brain .d 240 to 768 8 to 536 F91L A113D A114G A121T A122D ...     529/539
(98 %)
28 diff
(94.9 %id)
CA431206 cell lines, Enchondroma .d 240 to 798 577 to 19 exact AAA   559/565
(98 %)
1 diff
(99.9 %id)
BI768283 pooled lung and spleen .d 241 to 798 1 to 558 exact     558/914
(61 %)
1 diff
(99.9 %id)
BU502217 mixed (pool of 40 RNAs) .d 241 to 798 1 to 558 exact AAA   558/558
(100 %)
2 diff
(99.7 %id)
BU845385 ovary, teratocarcinoma, cell line .d 241 to 798 13 to 570 exact AAA   558/570
(97 %)
6 diff
(99.0 %id)
TI_57180503   .d 241 to 798 36 to 593 exact     558/949
(58 %)
7 diff
(99.3 %id)
BI758037 brain .d 242 to 798 1 to 555 Y39T R40E V41S T42H L43S ... AAA   555/555
(100 %)
3 diff
(99.5 %id)
BM920450 pooled lung and spleen .d 242 to 796 11 to 563 A2G P3H R7V Q8I Y9L ...     549/593
(92 %)
12 diff
(98.0 %id)
BU849986 ovary, teratocarcinoma, cell line .d 242 to 798 1 to 557 exact     557/913
(61 %)
1 diff
(99.9 %id)
ES309725 occipital hair of pubic hypotrichosispatient, skin .d 243 to 798 30 to 584 H19A R20P K21Q A22S Y23L ... AAA   555/584
(95 %)
6 diff
(99.0 %id)
BF527488 anaplastic oligodendroglioma with 1p/19qloss, brain .d 243 to 796 1 to 553 F70L G71A L72S T73P T74P ...     553/589
(93 %)
10 diff
(98.4 %id)
BF681648 Prostate .d 243 to 777 1 to 536 T16H D17R C18L H19P R20P ...     536/845
(63 %)
10 diff
(98.9 %id)
CA337707 1st pharyngeal arch (pooled) .d 243 to 796 1 to 554 exact     554/593
(93 %)
3 diff
(99.5 %id)
TI_57221387   .d 243 to 798 64 to 617 Y39T R40E V41S T42H L43S ... AAA   554/617
(89 %)
8 diff
(98.8 %id)
AW960514   .d 245 to 797 554 to 1 exact   Submitted on the opposite strand 554/651
(85 %)
7 diff
(99.0 %id)
CN370514 embryonic stem cells, DMSO-treated H9 cellline .d 245 to 664 1 to 420       420/420
(100 %)
2 diff
(99.6 %id)
BF185009 bone marrow, from chronic myelogenous leukemia .d 245 to 803 1 to 558 C18A H19T R20A A22P Y23T ...     558/923
(60 %)
6 diff
(99.4 %id)
BQ054257 blood, natural killer cells, cell line .d 245 to 798 1 to 554 exact AAA   554/554
(100 %)
0 diff
(100 %id)
BC069045 Uterus, leiomyosarcoma .d 246 to 796 1 to 551 exact available from MGC, AAA   551/551
(100 %)
0 diff
(100 %id)
TI_57163980   .d 246 to 804 26 to 584 exact AAA   559/584
(95 %)
10 diff
(98.3 %id)
ES313395 beard hair, skin .d 247 to 792 1 to 549 W133F E134G V135S F136V A137C ...     549/549
(100 %)
8 diff
(98.6 %id)
W40364 lung .d 247 to 692 1 to 442       442/444
(99 %)
15 diff
(96.7 %id)
BU902336 leiomyosarcoma, uterus .d 248 to 796 1 to 549 exact AAA   549/549
(100 %)
1 diff
(99.9 %id)
CN370511 embryonic stem cells, DMSO-treated H9 cellline .d 249 to 712 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BI160416 epithelioid carcinoma cell line, Pancreas .d 250 to 803 1 to 554 D14Y     554/571
(97 %)
4 diff
(99.3 %id)
BI834425 pooled pancreas and spleen .d 250 to 804 1 to 555 exact AAA   555/555
(100 %)
4 diff
(99.3 %id)
BU600393 mixed (pool of 40 RNAs) .d 250 to 786 1 to 544 V125G K126E A137G P139N K140P ...     544/809
(67 %)
16 diff
(98.1 %id)
BM920488 pooled lung and spleen .d 251 to 796 1 to 546 exact AAA   546/546
(100 %)
0 diff
(100 %id)
BG281093 melanotic melanoma, skin .d 252 to 798 1 to 547 P3L AAA   547/547
(100 %)
2 diff
(99.7 %id)
BG475525 melanotic melanoma, skin .d 252 to 761 1 to 535 Y9I W10L D11G I12Y D14R ...     533/837
(63 %)
41 diff
(95.2 %id)
BG770434 melanotic melanoma, high MDR (cell line), skin .d 252 to 799 1 to 547 exact     547/763
(71 %)
3 diff
(99.7 %id)
BU600021 mixed (pool of 40 RNAs) .d 253 to 797 1 to 545 exact     545/553
(98 %)
4 diff
(99.3 %id)
BU602784 mixed (pool of 40 RNAs) .d 253 to 748 1 to 501 V5A Y9H R81C D85H N89E ...     501/950
(52 %)
32 diff
(96.7 %id)
CB149423 Liver .d 253 to 794 1 to 542 exact AAA   542/542
(100 %)
0 diff
(100 %id)
CR747051 melanotic melanoma, skin .d 254 to 775 1 to 522 exact     522/522
(100 %)
5 diff
(99.1 %id)
TI_57214832   .d 254 to 798 36 to 581 K4E V5G R7S Q8S Y9V ...     546/942
(57 %)
7 diff
(99.3 %id)
BI752691 brain .d 255 to 798 1 to 545 K4E V5G R7S Q8S Y9V ...     545/906
(60 %)
2 diff
(99.8 %id)
BM917606 blood, natural killer cells, cell line .d 255 to 651 1 to 397       397/1452
(27 %)
6 diff
(99.6 %id)
H87810 eye, retina .d 257 to 547 1 to 290   fully sequenced,   290/290
(100 %)
7 diff
(97.6 %id)
BI833694 pooled pancreas and spleen .d 257 to 796 1 to 540 exact     540/546
(98 %)
1 diff
(99.9 %id)
BM918850 pooled pancreas and spleen .d 257 to 798 3 to 544 exact AAA   542/544
(99 %)
6 diff
(98.9 %id)
TI_57166779   .d 257 to 796 32 to 571 exact     540/577
(93 %)
7 diff
(98.8 %id)
AX775861   .d 258 to 796 1 to 539 exact     539/539
(100 %)
0 diff
(100 %id)
BJ994899 hepatoblastoma .d 260 to 798 1 to 539 exact fully sequenced,   539/539
(100 %)
1 diff
(99.9 %id)
TI_57165310   .d 260 to 768 24 to 531 Y9V W10L D11G I12Y D14R ...     508/712
(71 %)
10 diff
(98.6 %id)
BP419907 small intestine .d 262 to 796 1 to 535 exact   Submitted on the opposite strand 535/536
(99 %)
1 diff
(99.9 %id)
BG419055 Kidney, renal cell adenocarcinoma .d 262 to 798 1 to 537 exact AAA   537/551
(97 %)
2 diff
(99.7 %id)
BU603859 mixed (pool of 40 RNAs) .d 262 to 794 1 to 533 exact     533/574
(92 %)
5 diff
(99.2 %id)
AV751339 Pituitary .d 263 to 803 1 to 542 T74X D86E I120H A121S A122G ...     542/638
(84 %)
20 diff
(96.9 %id)
AA135694 uterus .d 264 to 745 1 to 481 K4X V5F R7V Q8S Y9T ...     479/481
(99 %)
20 diff
(95.9 %id)
BI824415 pooled brain, lung, testis .d 264 to 796 1 to 539 F6L Y59V T60H F61V T62H ...     537/950
(56 %)
6 diff
(99.4 %id)
BI823651 pooled brain, lung, testis .d 264 to 796 1 to 531 A114P C115A V116C Y117T F118L ... AAA   531/531
(100 %)
2 diff
(99.7 %id)
TI_57200757   .d 264 to 796 66 to 596 A114P C115A V116C Y117T F118L ... AAA   531/596
(89 %)
9 diff
(98.5 %id)
TI_57200833   .d 264 to 796 35 to 573 F6L Y59V T60H F61V T62H ...     537/984
(54 %)
10 diff
(99.0 %id)
BE562305 Burkitt lymphoma, lymph .d 265 to 800 40 to 574 exact     535/787
(67 %)
11 diff
(98.7 %id)
BU594762 mixed (pool of 40 RNAs) .d 267 to 796 1 to 530 exact     530/863
(61 %)
4 diff
(99.6 %id)
AA136957 uterus .d 268 to 464 1 to 197   fully sequenced,   197/197
(100 %)
4 diff
(98.0 %id)
AA126684 uterus .d 268 to 515 1 to 242   fully sequenced,   244/244
(100 %)
9 diff
(96.4 %id)
N32721 melanocyte .d 269 to 798 1 to 532 V5F R7V Q8S Y9T W10G ... AAA   532/532
(100 %)
23 diff
(95.7 %id)
AA282663 germinal center B cell .d 269 to 713 1 to 441       441/441
(100 %)
10 diff
(97.8 %id)
BF339961 brain, glioblastoma with EGFR amplification .d 269 to 794 1 to 528 L101S A103R R104H T105A H106R ...     528/859
(61 %)
10 diff
(98.9 %id)
BP418334 small intestine .d 270 to 796 12 to 538 exact AAA Submitted on the opposite strand 527/538
(97 %)
7 diff
(98.7 %id)
BI837750 pooled pancreas and spleen .d 270 to 768 1 to 498 Y9V W10L D11G I12Y D14R ...     498/679
(73 %)
4 diff
(99.5 %id)
AV654516 corresponding non cancerous liver tissue .d 271 to 690 1 to 420     Submitted on the opposite strand 420/420
(100 %)
1 diff
(99.8 %id)
AA406014 ovarian tumor, ovary .d 271 to 721 1 to 445   fully sequenced,   445/445
(100 %)
9 diff
(98.0 %id)
BU154397 eye, retinoblastoma .d 271 to 798 1 to 528 exact AAA   528/528
(100 %)
0 diff
(100 %id)
BQ427600 melanotic melanoma, skin .d 271 to 796 1 to 526 exact AAA   526/526
(100 %)
0 diff
(100 %id)
DN990205 brain, whole brain .d 271 to 796 1 to 526 exact AAA   526/526
(100 %)
6 diff
(98.9 %id)
BM709020 eye, RPE and Choroid .d 271 to 796 1 to 526 exact AAA   526/526
(100 %)
1 diff
(99.9 %id)
CN370512 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 272 to 798 1 to 527 exact     527/529
(99 %)
1 diff
(99.9 %id)
BG171086 hypernephroma, cell line, Kidney .d 272 to 798 1 to 527 K138X P139T AAA   527/527
(100 %)
1 diff
(99.9 %id)
BE728364 melanotic melanoma, skin .d 274 to 803 1 to 530 Y39T R40E V41S T42H L43S ...     530/535
(99 %)
9 diff
(98.4 %id)
AV703381 adrenal gland .d 275 to 698 1 to 424       424/424
(100 %)
0 diff
(100 %id)
CN370513 embryonic stem cells, cell lines H1, H7, andH9 .d 275 to 798 1 to 524 exact AAA   524/524
(100 %)
2 diff
(99.7 %id)
BG479400 choriocarcinoma, placenta .d 275 to 784 1 to 511 P139A     511/1023
(49 %)
6 diff
(99.5 %id)
BG744245 blood, natural killer cells, cell line .d 275 to 794 1 to 520 P139A fully sequenced, AAA   520/520
(100 %)
2 diff
(99.7 %id)
BM696058 eye, human retina .d 275 to 628 1 to 354       354/354
(100 %)
0 diff
(100 %id)
BG339196 leiomyosarcoma cell line, uterus .d 277 to 794 1 to 514 L88*     514/715
(71 %)
7 diff
(99.1 %id)
BP431875   .d 277 to 631 1 to 355       355/355
(100 %)
4 diff
(98.9 %id)
BM688908 eye, eye anterior segment .d 278 to 743 1 to 466 exact     466/466
(100 %)
5 diff
(99.0 %id)
AL711216 human skeletal muscle .d 279 to 754 1 to 476 exact     476/476
(100 %)
1 diff
(99.8 %id)
BU944990 mixed (pool of 40 RNAs) .d 279 to 796 1 to 518 exact     518/519
(99 %)
3 diff
(99.5 %id)
AV701178 adrenal gland .d 282 to 798 1 to 517 exact AAA   517/517
(100 %)
1 diff
(99.9 %id)
W21174 lung .d 282 to 453 1 to 173       173/173
(100 %)
8 diff
(95.4 %id)
BM926185 brain .d 282 to 796 38 to 551 V5G R7L Q8L Y9H W10*     514/1268
(40 %)
12 diff
(99.1 %id)
BU624547 cell lines, Enchondroma .d 282 to 798 536 to 19 K140X V141G AAA   518/518
(100 %)
1 diff
(99.9 %id)
BE513430 Burkitt lymphoma, lymph .d 284 to 803 1 to 520 exact     520/668
(77 %)
4 diff
(99.5 %id)
BU596915 mixed (pool of 40 RNAs) .d 284 to 794 1 to 511 exact     511/853
(59 %)
3 diff
(99.7 %id)
BE900211 choriocarcinoma, placenta .d 285 to 798 1 to 514 exact AAA   514/514
(100 %)
0 diff
(100 %id)
BE901112 choriocarcinoma, placenta .d 285 to 798 1 to 513 K4E V5G R7S Q8S Y9V ... AAA   513/513
(100 %)
4 diff
(99.3 %id)
BU623783 cell lines, Enchondroma .d 285 to 796 529 to 19 Y9S W10G D11I I12S D14M ... AAA   511/512
(99 %)
5 diff
(99.1 %id)
EL950273 eyeball .d 286 to 637 1 to 352       352/352
(100 %)
0 diff
(100 %id)
DB570254 hypothalamus .d 287 to 794 1 to 511 N89X N107X   Submitted on the opposite strand 511/511
(100 %)
6 diff
(98.9 %id)
AA045234.
matches multiple genes
uterus .d 287 to 798 509 to 6 V5F Y23T S24A T25P T26P ...   also hits gene FAM175AandHELQ 504/520
(96 %)
9 diff
(98.3 %id)
BQ574466 Chondrosarcoma Grade II, Left Pelvis .d 287 to 798 531 to 19 K140Q V141G AAA   513/522
(98 %)
1 diff
(99.9 %id)
BE562735 endometrium, adenocarcinoma cell line, uterus .d 290 to 803 1 to 523 E134R V135G F136V A137S K138Q ...     523/1052
(49 %)
13 diff
(98.8 %id)
BE562672 endometrium, adenocarcinoma cell line, uterus .d 290 to 788 1 to 507 G71W L72P T73H T74H C75L ...     507/747
(67 %)
12 diff
(98.4 %id)
CD109073 brain, Pituitary .d 290 to 798 1 to 509 exact AAA   509/509
(100 %)
0 diff
(100 %id)
BE733127 choriocarcinoma, placenta .d 291 to 800 1 to 510 A114P C115A V116C Y117T F118L ... AAA   510/510
(100 %)
7 diff
(98.7 %id)
BQ310469 breast .d 292 to 723 1 to 435       433/459
(94 %)
13 diff
(97.2 %id)
BM907560 large cell carcinoma, lung .d 292 to 798 522 to 16 exact AAA Submitted on the opposite strand 507/507
(100 %)
0 diff
(100 %id)
BM706582 eye, eye anterior segment .d 292 to 798 9 to 515 exact AAA   507/515
(98 %)
7 diff
(98.7 %id)
CB117398 Liver .d 293 to 714 1 to 421       421/428
(98 %)
5 diff
(98.9 %id)
BE513572 Burkitt lymphoma, lymph .d 294 to 798 1 to 505 exact     505/575
(87 %)
1 diff
(99.9 %id)
BG819245 anaplastic oligodendroglioma with 1p/19qloss, brain .d 294 to 796 1 to 499 C18A H19T R20A A22P Y23T ...     499/548
(91 %)
7 diff
(98.8 %id)
CB270719 adipose .d 295 to 798 1 to 505 R20P K21Q A22S Y23L S24Q ... AAA   505/505
(100 %)
2 diff
(99.7 %id)
BE254964 eye, retinoblastoma .d 295 to 798 1 to 509 A36R A37R A38C Y39L R40Q ...     509/729
(69 %)
6 diff
(99.2 %id)
CN370510 embryonic stem cells, DMSO-treated H9 cellline .d 296 to 795 1 to 500 exact     500/500
(100 %)
0 diff
(100 %id)
CB159706 Liver .d 296 to 771 1 to 476 exact     476/476
(100 %)
0 diff
(100 %id)
N92586 parathyroid gland, parathyroid tumor .d 300 to 798 505 to 23 P3Q K4V V5F F6R R7Q ... AAA   483/483
(100 %)
16 diff
(96.7 %id)
AI150878 heart .d 300 to 798 500 to 2 A32V     499/500
(99 %)
4 diff
(99.2 %id)
BE741920 adenocarcinoma cell line, ovary .d 301 to 798 1 to 502 A2R P3R K4L V5F R7V ... AAA   502/502
(100 %)
16 diff
(96.9 %id)
N94409 senescent fibroblast .d 305 to 798 505 to 16 V5F R7V Q8S Y9T W10G ... AAA   490/490
(100 %)
18 diff
(96.4 %id)
AJ539081 heart .d 306 to 731 1 to 426 exact     426/426
(100 %)
0 diff
(100 %id)
CD673863 eye, lens .d 307 to 761 1 to 455       455/455
(100 %)
0 diff
(100 %id)
AA527648 Ewing's sarcoma .d 307 to 644 15 to 349       335/353
(94 %)
20 diff
(94.4 %id)
BU625469 cell lines, Enchondroma .d 308 to 794 506 to 19   AAA   488/497
(98 %)
1 diff
(99.8 %id)
BY800077 eye .d 309 to 796 1 to 488       488/489
(99 %)
1 diff
(99.8 %id)
BE778285 eye, retinoblastoma .d 309 to 794 1 to 486       486/486
(100 %)
0 diff
(100 %id)
W93415 heart .d 319 to 798 479 to 3       477/481
(99 %)
10 diff
(98.0 %id)
AI311727 2 pooled tumors (clear cell type), Kidney .d 324 to 798 482 to 8       475/482
(98 %)
0 diff
(100 %id)
AW024373 Kidney .d 326 to 796 471 to 2       470/471
(99 %)
1 diff
(99.8 %id)
AI096685 heart .d 328 to 774 447 to 1       447/447
(100 %)
0 diff
(100 %id)
BI861251 breast, mammary adenocarcinoma, cell line .d 329 to 797 40 to 508   AAA   469/539
(87 %)
9 diff
(98.4 %id)
TI_57193033   .d 329 to 797 97 to 565       469/909
(51 %)
9 diff
(99.1 %id)
AL702102 human skeletal muscle .d 331 to 754 1 to 424       424/424
(100 %)
0 diff
(100 %id)
AJ572215 pectoral muscle (after mastectomy) .d 335 to 757 1 to 424       424/424
(100 %)
1 diff
(99.8 %id)
AJ573981 pectoral muscle (after mastectomy) .d 335 to 637 1 to 304       304/304
(100 %)
3 diff
(99.1 %id)
AA628427   .d 341 to 798 478 to 25       454/478
(94 %)
8 diff
(98.4 %id)
DB528351 hippocampus .d 342 to 794 1 to 453     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
AW328001 Burkitt lymphoma, lymph .d 342 to 781 1 to 440       440/440
(100 %)
2 diff
(99.6 %id)
TI_153958049   .d 343 to 796 84 to 538       455/927
(49 %)
7 diff
(99.3 %id)
AW183720 pooled .d 344 to 798 464 to 10       455/464
(98 %)
3 diff
(99.4 %id)
AJ346457 pectoral muscle (after mastectomy) .d 345 to 717 1 to 373       373/373
(100 %)
1 diff
(99.8 %id)
AJ572721 pectoral muscle (after mastectomy) .d 345 to 638 1 to 294       294/294
(100 %)
0 diff
(100 %id)
BE900751 choriocarcinoma, placenta .d 345 to 798 1 to 454   AAA   454/454
(100 %)
0 diff
(100 %id)
BQ675635 epidermoid carcinoma, cell line, salivary gland .d 345 to 794 1 to 450   AAA   450/452
(99 %)
8 diff
(98.3 %id)
AI568498 anaplastic oligodendroglioma, brain .d 346 to 796 452 to 2       451/452
(99 %)
0 diff
(100 %id)
AI733407 2 pooled tumors (clear cell type), Kidney .d 348 to 796 454 to 6       449/454
(98 %)
0 diff
(100 %id)
TI_57190190   .d 348 to 758 51 to 461       411/792
(51 %)
1 diff
(99.9 %id)
BI856322 breast, mammary adenocarcinoma, cell line .d 350 to 758 1 to 409       409/790
(51 %)
1 diff
(99.9 %id)
AJ346248 pectoral muscle (after mastectomy) .d 352 to 778 1 to 427       427/427
(100 %)
1 diff
(99.8 %id)
AI885319 anaplastic oligodendroglioma, brain .d 352 to 798 455 to 9       447/455
(98 %)
0 diff
(100 %id)
AI346415 adenocarcinoma, colon .d 357 to 798 444 to 2       443/444
(99 %)
3 diff
(99.4 %id)
AI056320 brain, glioblastoma (pooled) .d 361 to 796 444 to 9       436/444
(98 %)
0 diff
(100 %id)
BF446178 Prostate .d 367 to 798 439 to 8       432/439
(98 %)
1 diff
(99.8 %id)
BF195616 fibrotheoma, ovary .d 369 to 798 433 to 4       430/433
(99 %)
0 diff
(100 %id)
BJ994900 hepatoblastoma .d 372 to 761 390 to 1   fully sequenced,   390/390
(100 %)
0 diff
(100 %id)
BG744977 blood, natural killer cells, cell line .d 372 to 744 372 to 1   fully sequenced,   372/372
(100 %)
4 diff
(99.0 %id)
BM770369 Ascites, stomach .d 372 to 798 1 to 427   AAA   427/427
(100 %)
0 diff
(100 %id)
BM771509 Ascites, stomach .d 372 to 798 1 to 427   AAA   427/427
(100 %)
0 diff
(100 %id)
AI074058 senescent fibroblast .d 373 to 796 429 to 6       424/429
(98 %)
0 diff
(100 %id)
AI086428 anaplastic oligodendroglioma, brain .d 373 to 798 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AI084153 anaplastic oligodendroglioma, brain .d 374 to 796 423 to 1       423/423
(100 %)
0 diff
(100 %id)
BE714497 head_neck .d 376 to 750 377 to 3       375/390
(96 %)
1 diff
(99.8 %id)
N51050 liver and spleen .d 377 to 794 415 to 1       415/415
(100 %)
13 diff
(96.9 %id)
AI216110 carcinoid, lung .d 384 to 798 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AI278010 placenta .d 384 to 796 421 to 9       413/421
(98 %)
0 diff
(100 %id)
AJ346389 pectoral muscle (after mastectomy) .d 385 to 666 1 to 282       282/282
(100 %)
0 diff
(100 %id)
AI475836 B-cell, chronic lymphotic leukemia .d 385 to 798 420 to 7       414/420
(98 %)
0 diff
(100 %id)
BE439989 Trabecular meshwork .d 386 to 798 451 to 39       413/451
(91 %)
4 diff
(99.2 %id)
AI612824 ovary, tumor, 5 pooled (see description) .d 386 to 796 412 to 2       411/412
(99 %)
0 diff
(100 %id)
AI264151 Kidney .d 388 to 798 413 to 3       411/413
(99 %)
0 diff
(100 %id)
AA977263 2 pooled tumors (clear cell type), Kidney .d 390 to 796 425 to 5       419/438
(95 %)
34 diff
(92.3 %id)
AA099367 uterus .d 391 to 794 409 to 7       403/452
(89 %)
13 diff
(97.2 %id)
AA761493 germinal center B cell .d 391 to 794 419 to 22   AAA   398/460
(86 %)
17 diff
(96.4 %id)
AI140592   .d 391 to 796 421 to 16   AAA   406/406
(100 %)
0 diff
(100 %id)
AJ572244 pectoral muscle (after mastectomy) .d 395 to 781 8 to 394       387/394
(98 %)
0 diff
(100 %id)
AJ573277 pectoral muscle (after mastectomy) .d 395 to 796 1 to 402       402/402
(100 %)
4 diff
(99.1 %id)
BP418411 small intestine .d 396 to 798 1 to 403   AAA Submitted on the opposite strand 403/403
(100 %)
0 diff
(100 %id)
AA861934 parathyroid gland, parathyroid tumor .d 396 to 798 415 to 15   AAA   401/401
(100 %)
3 diff
(99.3 %id)
AA570311 colon, colon tumor RER+ .d 397 to 798 401 to 1       401/404
(99 %)
7 diff
(98.3 %id)
AI186172 lung .d 397 to 798 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AI708821 aorta .d 398 to 803 410 to 5       406/410
(99 %)
2 diff
(99.6 %id)
AA365658 pineal body .d 400 to 713 1 to 315       315/316
(99 %)
5 diff
(98.5 %id)
AA947063 Kidney, kidney tumor .d 403 to 765 360 to 1       360/360
(100 %)
7 diff
(98.1 %id)
F26482 pectoral muscle (after mastectomy) .d 403 to 687 1 to 285       285/285
(100 %)
2 diff
(99.3 %id)
BM672795 eye, optic nerve .d 403 to 796 413 to 19   AAA   395/395
(100 %)
1 diff
(99.8 %id)
AJ573429 pectoral muscle (after mastectomy) .d 405 to 718 1 to 314       314/314
(100 %)
0 diff
(100 %id)
N25165 melanocyte .d 405 to 789 4 to 408       420/415
(101 %)
81 diff
(80.5 %id)
CN292243 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 407 to 796 1 to 390       390/390
(100 %)
0 diff
(100 %id)
BF947149 nervous_normal .d 412 to 677 265 to 2       264/297
(88 %)
2 diff
(99.4 %id)
BU957849 mixed (pool of 40 RNAs) .d 415 to 795 1 to 381       381/390
(97 %)
3 diff
(99.3 %id)
AA719714 pineal gland .d 418 to 794 383 to 8       376/383
(98 %)
4 diff
(99.0 %id)
AI292049 placenta .d 419 to 798 391 to 12   AAA   380/380
(100 %)
0 diff
(100 %id)
F28679 pectoral muscle (after mastectomy) .d 421 to 652 1 to 231       231/231
(100 %)
1 diff
(99.6 %id)
AA708795 uterus .d 429 to 798 368 to 1       368/368
(100 %)
4 diff
(99.0 %id)
AA923526 2 pooled tumors (clear cell type), Kidney .d 431 to 798 372 to 7       366/372
(98 %)
6 diff
(98.4 %id)
AA136864 uterus .d 434 to 796 361 to 1   fully sequenced,   361/361
(100 %)
8 diff
(97.8 %id)
AI126439   .d 436 to 798 379 to 17   AAA   363/363
(100 %)
2 diff
(99.5 %id)
AA837038 lung, small cell carcinoma .d 437 to 796 371 to 13       359/371
(96 %)
2 diff
(99.5 %id)
AA830011 germinal center B cell .d 438 to 746 307 to 1       307/307
(100 %)
3 diff
(99.1 %id)
AI051818 parathyroid gland, parathyroid tumor .d 440 to 798 368 to 12   AAA   357/357
(100 %)
8 diff
(97.8 %id)
AI073678 senescent fibroblast .d 441 to 798 362 to 7       356/362
(98 %)
3 diff
(99.2 %id)
AI720142 colon .d 441 to 798 362 to 5       358/362
(98 %)
0 diff
(100 %id)
AI350889 pooled germ cell tumors .d 442 to 798 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AA923528 2 pooled tumors (clear cell type), Kidney .d 451 to 798 352 to 7       346/352
(98 %)
3 diff
(99.2 %id)
AI918344 anaplastic oligodendroglioma, brain .d 452 to 796 346 to 1       346/346
(100 %)
1 diff
(99.8 %id)
AI188859 placenta .d 459 to 798 358 to 19   AAA   340/340
(100 %)
4 diff
(98.9 %id)
R71258 placenta .d 465 to 798 335 to 3   fully sequenced,   333/335
(99 %)
9 diff
(97.4 %id)
AA156823 uterus .d 465 to 796 330 to 1   fully sequenced,   330/330
(100 %)
3 diff
(99.1 %id)
AA365364 pineal body .d 466 to 798 1 to 334       334/334
(100 %)
4 diff
(98.9 %id)
AA365363 pineal body .d 467 to 798 333 to 1       333/348
(95 %)
3 diff
(99.2 %id)
AJ572164 pectoral muscle (after mastectomy) .d 469 to 727 9 to 266       258/266
(96 %)
8 diff
(97.0 %id)
BE151181 head_neck .d 473 to 798 3 to 329       327/362
(90 %)
9 diff
(97.6 %id)
AA524443 colon .d 480 to 794 313 to 1       313/315
(99 %)
7 diff
(97.8 %id)
AJ573694 pectoral muscle (after mastectomy) .d 484 to 797 1 to 314   AAA   314/314
(100 %)
8 diff
(97.5 %id)
AI268100 carcinoid, lung .d 484 to 801 318 to 1       318/318
(100 %)
0 diff
(100 %id)
AI338201 lung .d 492 to 798 314 to 7       308/314
(98 %)
0 diff
(100 %id)
AI272174 brain, oligodendroglioma .d 492 to 803 321 to 8   tiling clone,   314/323
(97 %)
2 diff
(99.4 %id)
N29714.
matches multiple genes
placenta .d 494 to 798 323 to 22   AAA also hits gene SNTB1 302/317
(95 %)
8 diff
(97.5 %id)
BX474089   .d 497 to 796 154 to 453       300/456
(65 %)
8 diff
(98.3 %id)
N92983 lung .d 504 to 794 305 to 4       254/305
(83 %)
5 diff
(98.4 %id)
BQ372540 prostate_normal .d 516 to 635 8 to 129       122/129
(94 %)
6 diff
(95.4 %id)
H87761 eye, retina .d 517 to 781 263 to 1   fully sequenced,   263/263
(100 %)
5 diff
(98.1 %id)
F19399 pectoral muscle (after mastectomy) .d 519 to 798 1 to 280       280/281
(99 %)
1 diff
(99.7 %id)
AI368468 brain, glioblastoma (pooled) .d 528 to 798 272 to 1       272/272
(100 %)
3 diff
(98.9 %id)
DR980789 placenta .d 540 to 798 1 to 254   AAA Submitted on the opposite strand 254/254
(100 %)
9 diff
(96.5 %id)
AI241000 Kidney .d 540 to 798 281 to 23   AAA   259/259
(100 %)
10 diff
(96.2 %id)
BF752272 breast_normal .d 546 to 798 16 to 267       252/294
(85 %)
8 diff
(97.3 %id)
BG677753 skin, squamous cell carcinoma .d 554 to 796 1 to 243   AAA   243/243
(100 %)
0 diff
(100 %id)
AI620422 Prostate .d 562 to 796 237 to 3       235/237
(99 %)
0 diff
(100 %id)
AA722701 heart .d 571 to 794 222 to 1       222/295
(75 %)
2 diff
(99.4 %id)
BF508740   .d 583 to 798 233 to 18   AAA   216/216
(100 %)
1 diff
(99.6 %id)
FN105159 breast carcinoma .d 608 to 714 1 to 108       108/108
(100 %)
3 diff
(97.3 %id)
EC569819 Prostate .d 614 to 722 1 to 110       110/111
(99 %)
6 diff
(94.6 %id)
FN103328 breast carcinoma .d 619 to 677 59 to 1     Submitted on the opposite strand 59/73
(80 %)
0 diff
(100 %id)
AA688392 normal prostate, Prostate .d 619 to 798 179 to 1       179/184
(97 %)
1 diff
(99.5 %id)
EC574258 Prostate .d 621 to 719 12 to 110       99/113
(87 %)
3 diff
(97.4 %id)
AI370556   .d 625 to 798 174 to 1       174/174
(100 %)
0 diff
(100 %id)
BP395510 pancreatic islet .d 627 to 796 1 to 171     Submitted on the opposite strand 171/177
(96 %)
2 diff
(98.9 %id)
AW170117 cervix, tumor .d 629 to 798 176 to 7       170/176
(96 %)
0 diff
(100 %id)
AI351734   .d 630 to 796 170 to 4       167/170
(98 %)
0 diff
(100 %id)
AA459520 ovarian tumor, ovary .d 631 to 780 12 to 160   fully sequenced,   149/160
(93 %)
6 diff
(96.3 %id)
AA459533 ovarian tumor, ovary .d 631 to 780 13 to 161   fully sequenced,   149/161
(92 %)
6 diff
(96.3 %id)
AA593011 colon, colon tumor RER+ .d 637 to 794 188 to 32   AAA   157/158
(99 %)
1 diff
(99.4 %id)
AA721382 germinal center B cell .d 637 to 798 183 to 22   AAA   162/162
(100 %)
0 diff
(100 %id)
EC486273 Prostate .d 638 to 747 1 to 110       110/110
(100 %)
2 diff
(98.2 %id)
EC566362 Prostate .d 638 to 741 1 to 104       104/104
(100 %)
2 diff
(98.1 %id)
EC540291 Prostate .d 639 to 748 1 to 111       111/111
(100 %)
1 diff
(99.1 %id)
EC556509 Prostate .d 639 to 747 1 to 109       109/109
(100 %)
0 diff
(100 %id)
AI338112 lung .d 640 to 796 158 to 2       157/158
(99 %)
0 diff
(100 %id)
AI051481 parathyroid gland, parathyroid tumor .d 643 to 798 162 to 8       155/162
(95 %)
0 diff
(100 %id)
FN112186 breast carcinoma .d 649 to 758 1 to 112       112/112
(100 %)
2 diff
(98.3 %id)
AI186053 lung .d 667 to 795 129 to 1       129/129
(100 %)
0 diff
(100 %id)
AI249960 adenocarcinoma, Pancreas .d 667 to 798 144 to 13   AAA   132/132
(100 %)
0 diff
(100 %id)
AI766353 Kidney .d 667 to 798 142 to 11   AAA   132/132
(100 %)
0 diff
(100 %id)
FN057856 breast carcinoma .d 689 to 790 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
AA402901 ovarian tumor, ovary .d 691 to 796 106 to 1   fully sequenced,   106/106
(100 %)
2 diff
(98.2 %id)
EC470215 Prostate .d 694 to 793 100 to 4       97/100
(97 %)
0 diff
(100 %id)
BF981655 duodenal adenocarcinoma, cell line, small intestine .d 696 to 798 14 to 116   AAA   103/116
(88 %)
6 diff
(94.9 %id)
EC562356 Prostate .d 699 to 795 109 to 14       96/109
(88 %)
0 diff
(100 %id)
F16938 pectoral muscle (after mastectomy) .d 704 to 798 1 to 95       95/96
(98 %)
2 diff
(98.0 %id)
FN119104 breast carcinoma .d 708 to 796 86 to 1     Submitted on the opposite strand 86/95
(90 %)
3 diff
(96.9 %id)
AA459302 ovarian tumor, ovary .d 711 to 798 88 to 1   fully sequenced,   88/88
(100 %)
0 diff
(100 %id)
AA459290 ovarian tumor, ovary .d 712 to 798 87 to 1   fully sequenced,   87/87
(100 %)
0 diff
(100 %id)
EC527456 Prostate .d 731 to 797 1 to 67       67/71
(94 %)
1 diff
(98.6 %id)
DA729342   .e 1 to 768 2 to 768   tiling clone, capped   767/767
(100 %)
8 diff
(99.0 %id)
AJ706436 bone marrow .e 24 to 224 1 to 204       204/204
(100 %)
7 diff
(96.6 %id)
AA302322 aorta .e 27 to 269 1 to 242       242/244
(99 %)
4 diff
(98.4 %id)
AA365915 pineal body .e 31 to 272 1 to 242       242/242
(100 %)
7 diff
(97.2 %id)
AA317367 retina .e 42 to 311 1 to 270       270/270
(100 %)
2 diff
(99.3 %id)
AA338937 brain .e 42 to 306 1 to 265       265/265
(100 %)
1 diff
(99.7 %id)
D80404 brain .e 59 to 475 1 to 417       417/417
(100 %)
14 diff
(96.7 %id)
AA074461 pineal gland .e 59 to 244 1 to 186       186/188
(98 %)
8 diff
(95.8 %id)
AA058810.
matches multiple genes
uterus .e 59 to 251 1 to 192     also hits gene farwey 192/194
(98 %)
4 diff
(98.0 %id)
AA302608 aorta .e 66 to 311 1 to 245       245/245
(100 %)
4 diff
(98.4 %id)
F36645 pectoral muscle (after mastectomy) .e 159 to 363 9 to 213       205/213
(96 %)
6 diff
(97.2 %id)
BF357992 leiomios .e 201 to 380 183 to 3       181/183
(98 %)
3 diff
(98.4 %id)
BE926391 breast .e 202 to 382 9 to 189       181/189
(95 %)
6 diff
(96.9 %id)
FN122723 breast carcinoma .e 205 to 307 1 to 101       101/101
(100 %)
2 diff
(98.1 %id)
F32362 pectoral muscle (after mastectomy) .e 208 to 349 1 to 142       142/142
(100 %)
6 diff
(95.8 %id)
FN160517 breast carcinoma .e 225 to 314 86 to 1     Submitted on the opposite strand 86/95
(90 %)
4 diff
(95.8 %id)
EC556203 Prostate .e 230 to 328 1 to 99       99/99
(100 %)
0 diff
(100 %id)
FN076985 breast carcinoma .e 257 to 353 1 to 96       96/100
(96 %)
2 diff
(98.0 %id)
F34005 pectoral muscle (after mastectomy) .e 266 to 352 10 to 96       87/96
(90 %)
6 diff
(93.8 %id)
FN130176 breast carcinoma .e 271 to 342 1 to 70       70/71
(98 %)
3 diff
(95.8 %id)
FN056816 breast carcinoma .e 277 to 374 99 to 1     Submitted on the opposite strand 99/99
(100 %)
1 diff
(99.0 %id)
NM_002034.2   .e 476 to 2463 1 to 1988   RefSeq,   1988/1988
(100 %)
0 diff
(100 %id)
U27329 colon, liver .e 476 to 2273 1 to 1799       1799/1799
(100 %)
9 diff
(99.5 %id)
U27330 colon, liver .e 476 to 2463 1 to 1988   tiling clone,   1988/1988
(100 %)
10 diff
(99.5 %id)
TI_1971556609   .e 478 to 1459 130 to 1104   tiling clone, Submitted on the opposite strand 975/1275
(76 %)
25 diff
(98.1 %id)
TI_1971556701   .e 478 to 1306 835 to 8       828/1277
(64 %)
0 diff
(100 %id)
DA946531 Spleen .f 1 to 586 2 to 589 A2L tiling clone, capped   588/588
(100 %)
2 diff
(99.7 %id)
BM919880 pooled pancreas and spleen .f 16 to 857 1 to 847 exact tiling clone,   847/1019
(83 %)
9 diff
(99.2 %id)
CN370508 embryonic stem cells, cell lines H1, H7, andH9 .f 40 to 589 6 to 556 W107V P108A P110S H111P H113P ...     551/556
(99 %)
7 diff
(98.8 %id)
BG911795 anaplastic oligodendroglioma with 1p/19qloss, brain .f 40 to 404 1 to 366   AAA   366/609
(60 %)
7 diff
(98.9 %id)
H85994 eye, retina .f 46 to 274 1 to 231       231/303
(76 %)
4 diff
(98.7 %id)
AA059174 eye, retina .f 46 to 293 1 to 248       248/253
(98 %)
8 diff
(96.9 %id)
CN370507 embryonic stem cells, cell lines H1, H7, andH9 .f 62 to 401 1 to 340       340/340
(100 %)
1 diff
(99.8 %id)
CX761895 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 119 to 857 1 to 738     Submitted on the opposite strand 738/738
(100 %)
16 diff
(97.9 %id)
AA324852 brain, cerebellum .f 152 to 488 1 to 340       340/340
(100 %)
12 diff
(96.5 %id)
BM553404 duodenal adenocarcinoma, cell line, small intestine .f 229 to 794 1 to 571       571/1396
(40 %)
17 diff
(98.8 %id)
CR604632 Placenta Cot 25-normalized .f 626 to 2004 1 to 1379   tiling clone,   1379/1379
(100 %)
0 diff
(100 %id)
BX379818 Placenta Cot 25-normalized .f 626 to 1703 1 to 1060       1060/1060
(100 %)
21 diff
(98.1 %id)
BM805028 ovary (pool of 3) .f 782 to 1584 26 to 838       813/1121
(72 %)
22 diff
(98.1 %id)
BX379817 Placenta Cot 25-normalized .f 1019 to 2105 1108 to 35       1074/1117
(96 %)
17 diff
(98.5 %id)
CD723182 eye, lacrimal gland .f 1077 to 1676 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
TI_57151497   .f 1108 to 1830 68 to 792       725/891
(81 %)
6 diff
(99.4 %id)
BI762274 pooled colon, kidney, stomach .f 1109 to 1830 1 to 724       724/823
(87 %)
6 diff
(99.3 %id)
BM823465 Ascites, stomach .f 1201 to 1770 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
CR603223 thymus .f 1348 to 2152 1 to 805       805/805
(100 %)
0 diff
(100 %id)
BX436944 thymus .f 1348 to 2167 1 to 821       821/821
(100 %)
27 diff
(96.8 %id)
BF951991 nervous_normal .f 1356 to 1832 496 to 21       476/496
(95 %)
0 diff
(100 %id)
BM856137 stomach .f 1424 to 1601 1 to 178       178/178
(100 %)
0 diff
(100 %id)
BX369245 Placenta Cot 25-normalized .f 1530 to 1879 1 to 352       352/359
(98 %)
5 diff
(98.7 %id)
BX369246 Placenta Cot 25-normalized .f 1530 to 2172 1 to 645       645/645
(100 %)
4 diff
(99.4 %id)
BQ575508 Chondrosarcoma Grade II, Left Pelvis .f 1532 to 2173 661 to 19   tiling clone, AAA   643/643
(100 %)
1 diff
(99.9 %id)
CN282478 embryonic stem cells, cell lines H1, H7, andH9 .f 1546 to 1933 36 to 424       389/424
(91 %)
6 diff
(98.6 %id)
AL360263   .f 1555 to 2155 617 to 18     Submitted on the opposite strand 600/617
(97 %)
0 diff
(100 %id)
BX348298.
matches multiple genes
placenta, Placenta Cot 25-normalized .f 1556 to 2168 25 to 635     also hits gene SLC17A5 611/641
(95 %)
46 diff
(92.9 %id)
BQ642735 lymph, lymphoma, cell line .f 1557 to 2172 1 to 616   tiling clone, AAA   616/616
(100 %)
0 diff
(100 %id)
AA521069 germinal center B cell .f 1591 to 2172 610 to 22   AAA   589/589
(100 %)
68 diff
(88.5 %id)
BU781923.
matches multiple genes
insulinoma, Pancreas .f 1620 to 2166 27 to 573   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base), also hits gene shergly 547/573
(95 %)
6 diff
(99.0 %id)
AI743115 pooled .f 1655 to 2170 528 to 13   AAA   516/516
(100 %)
8 diff
(98.5 %id)
BU782826.
matches multiple genes
insulinoma, Pancreas .f 1706 to 2172 482 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base), also hits gene shergly 467/467
(100 %)
0 diff
(100 %id)
AA552290 colon, tumor .f 1707 to 2170 477 to 14   AAA   464/464
(100 %)
1 diff
(99.8 %id)
AA052921 eye, retina .f 1717 to 2152 439 to 1       439/444
(98 %)
11 diff
(97.6 %id)
AI148851 placenta .f 1719 to 2172 459 to 6       454/459
(98 %)
0 diff
(100 %id)
AA059116 eye, retina .f 1724 to 2152 429 to 1       429/430
(99 %)
6 diff
(98.7 %id)
AI417622 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 1727 to 2170 451 to 8       444/451
(98 %)
0 diff
(100 %id)
BF847680 lung_normal .f 1738 to 1971 241 to 8     Submitted on the opposite strand 234/242
(96 %)
0 diff
(100 %id)
AI144385 heart .f 1753 to 2172 423 to 4       420/423
(99 %)
0 diff
(100 %id)
AA001099 eye, retina .f 1756 to 2153 400 to 1       400/403
(99 %)
7 diff
(98.3 %id)
AI493540 adenocarcinoma, Pancreas .f 1772 to 2172 402 to 3       400/405
(98 %)
0 diff
(100 %id)
AA552247 colon, tumor .f 1774 to 2170 410 to 14   AAA   397/397
(100 %)
2 diff
(99.5 %id)
H86354 eye, retina .f 1822 to 2136 331 to 1       331/331
(100 %)
20 diff
(94.0 %id)
AA738233 pooled germ cell tumors .f 1827 to 2172 346 to 1       346/346
(100 %)
5 diff
(98.6 %id)
AW273385 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 1829 to 2172 349 to 6       344/349
(98 %)
0 diff
(100 %id)
AA769847   .f 1839 to 2172 345 to 12   AAA   334/334
(100 %)
0 diff
(100 %id)
AI873488 pooled .f 1878 to 2172 308 to 12   AAA   297/297
(100 %)
6 diff
(98.0 %id)
H37792 eye, retina .f 1882 to 2152 272 to 1       272/272
(100 %)
6 diff
(97.8 %id)
AA524197 colon .f 1899 to 2172 274 to 3       272/274
(99 %)
0 diff
(100 %id)
AA973224 pooled germ cell tumors .f 1927 to 2172 245 to 1       245/245
(100 %)
2 diff
(99.2 %id)
CR602109 Placenta Cot 25-normalized .g 1 to 657 1 to 657 exact     657/657
(100 %)
0 diff
(100 %id)
AL546175 placenta, Placenta Cot 25-normalized .g 1 to 657 1 to 656 L71* fully sequenced,   656/656
(100 %)
5 diff
(99.3 %id)
AA188060   .g 1 to 533 1 to 535       535/535
(100 %)
21 diff
(96.1 %id)
NR_034166.1   .g 1 to 659 1 to 659 exact RefSeq, tiling clone, AAA   659/659
(100 %)
0 diff
(100 %id)
BM691486 eye, RPE and Choroid .g 6 to 452 1 to 447       447/447
(100 %)
7 diff
(98.5 %id)
H25662 breast .g 34 to 264 1 to 230       230/233
(98 %)
5 diff
(97.9 %id)
AA452001   .g 59 to 549 1 to 487       487/487
(100 %)
4 diff
(99.2 %id)
N78342 multiple sclerosis lesions .g 66 to 294 1 to 235   fully sequenced,   235/235
(100 %)
4 diff
(98.3 %id)
TI_151737523   .g 107 to 659 652 to 100 exact AAA   553/554
(99 %)
3 diff
(99.5 %id)
AI089903 brain, glioblastoma (pooled) .g 193 to 655 469 to 7 exact     463/469
(98 %)
0 diff
(100 %id)
AW083811 colon, moderately differentiated adenocarcinoma .g 211 to 655 450 to 6 D57T     445/450
(98 %)
2 diff
(99.6 %id)
CU448202 epidermis .g 231 to 590 374 to 15     Submitted on the opposite strand 360/387
(93 %)
1 diff
(99.8 %id)
AL546174 placenta, Placenta Cot 25-normalized .g 233 to 616 391 to 10 G66A C67A A68P G69E G70A ... fully sequenced,   382/391
(97 %)
4 diff
(99.0 %id)
N62111 multiple sclerosis lesions .g 233 to 657 422 to 1 F2V S4I G5S N16K P17S ... fully sequenced,   422/422
(100 %)
9 diff
(97.9 %id)
H26248 breast .g 269 to 645 400 to 11       390/401
(97 %)
18 diff
(95.6 %id)
BI160094 epithelioid carcinoma cell line, Pancreas .h 1 to 590 1 to 591 P5T tiling clone, AAA   591/591
(100 %)
5 diff
(99.2 %id)
BI917820 brain .i 1 to 327 1 to 327 exact tiling clone,   327/396
(82 %)
1 diff
(99.8 %id)
TI_57243942   .i 1 to 327 31 to 357 exact AAA   327/413
(79 %)
7 diff
(98.4 %id)
CR736492   .j-u 1 to 222 37 to 258   tiling clone, AAA   222/258
(86 %)
6 diff
(97.7 %id)
BP424051 small intestine .j-u 27 to 436 1 to 411 H2T tiling clone, Submitted on the opposite strand 411/411
(100 %)
3 diff
(99.3 %id)
AI125604   .j-u 32 to 222 200 to 10       191/200
(95 %)
0 diff
(100 %id)
AA620921   .j-u 39 to 335 300 to 4 P10A G13A A14G C15A A16R ...     297/300
(99 %)
0 diff
(100 %id)
BX403246 Placenta Cot 25-normalized .j-u 51 to 436 1 to 387 exact tiling clone,   387/405
(95 %)
11 diff
(97.3 %id)
AA359640 lung .j-u 56 to 270 1 to 216 S6X R17E S18F M19H S20V ...     216/216
(100 %)
7 diff
(96.8 %id)
AY726561 testis Gene NDUFA11andFUT5, variant not shown       AAA This clone was ignored    
BC140905 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones Gene NDUFA11andFUT5, variant not shown         Suspected internal deletion, this clone was ignored    
AK291087   Gene NDUFA11andFUT5, variant not shown         Suspected internal deletion, this clone was ignored    
TI_1971553553   Gene NDUFA11andFUT5, variant not shown         Submitted on the opposite strand    
TI_1971554073   Gene NDUFA11andFUT5, variant not shown         Suspected internal deletion, this clone was ignored    
BG341662 B-cells, primary B-cells from tonsils (cell line) Gene NDUFA11andFUT5, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC